Increase of melanogenesis by retinoic acid: An ultrastructural and morphometric study

Tissue and Cell

Volumn 36, Issue 2, 2004, Pages 95-105

  Fernandes, Simon Souza ^a   Arcuri, R ^a   Morgado Diaz J A ^a   Benchimol, M ^b  

^a INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^b Universidade Santa Ursula   (Brazil)

Author keywords

B16F10 cells; Electron microscopy; Melanogenesis; Morphometry; Retinoic acid

Indexed keywords

MELANIN; MONOCLONAL ANTIBODY HMB 45; RETINOIC ACID;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CELL COUNT; CELL DENSITY; CELL NUCLEUS; CELL ORGANELLE; CELL STRUCTURE; CELL ULTRASTRUCTURE; CELL VOLUME; CONTROLLED STUDY; ELECTRON MICROSCOPY; FLOW CYTOMETRY; IMMUNOELECTRON MICROSCOPY; IMMUNOFLUORESCENCE; IMMUNOGOLD ELECTRON MICROSCOPY; MELANOGENESIS; MELANOMA B16; MELANOMA CELL; MELANOSOME; METASTASIS INHIBITION; MORPHOMETRICS; MOUSE; NONHUMAN; NUCLEOLUS; QUANTITATIVE ANALYSIS; SKIN PIGMENTATION; SKIN PROTECTION; ULTRAVIOLET RADIATION;

EID: 1642484178     PISSN: 00408166     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tice.2003.10.006     Document Type: Article

References (41)

1. + ATPase inhibitors in amelanotic, tyrosinase positive human and mouse melanoma cells. FEBS Lett. 478, 57-60.
2. Aroca, P., Urabe, K., Kobayashi, T., Tsukamoto, K., Hearing, V.J., 1993. Melanin biosynthesis patterns following hormonal stimulation. J. Biol. Chem. 268, 25650-25655.
3. Baroni, A., Paoletti, I., Silvestri, I., Buommino, E., Carriero, M.V., 2003. Early vitronectin receptor downregulation in a melanoma cell line during all-trans retinoic acid-induced apoptosis. Br. J. Dermatol. 148, 424-433.
4. Beitner, H., Wennersten, G., 1985. A qualitative and quantitative transmission electron microscopic study of the immediate pigment darkening reaction. Photodermatology 2, 273-278.
5. Bozzola, J.J., Russel, L.D., 1991. Electron microscopy principles and techniques for biologists. In: Quantitative electron microscopy. Jones and Bartlett Publishers, Boston, USA, pp. 288-304.
6. Bicamumpaka, C., Page, M., 1999. Paclitaxel stimulates melanogenesis in B16-F1 melanoma cells. Anticancer Res. 18, 4101-4104.
7. Chandraratna, R.A.S., 1998. Future trends: A new generation of retinoids. J. Am. Acad. Dermatol. 39, 49-52.
8. De Brabander, M., Borges, M., 1975. The formation of annulated lamellae induced by the disintegration of microtubules. J. Cell. Sci. 19, 331-340.
9. Edward, M., Gold, J.A., Mackie, R.M., 1988. Different susceptibilities of melanoma cell to retinoic acid-induced changes in melanotic expression. Biochem. Biophys. Res. Common. 155, 773-778.
10. Helige, C., Smolle, J., Zellnig, G., Hartmann, E., Fink-Puches, R., Kerl, H., Tritthart, A., 1993. Inhibition of K1735-M2 melanoma cell invasion in vitro by retinoic acid. Clin. Exp. Metastasis 11, 409-418.
11. Hendrix, M.J.S., Wood, R., Seftor, E.A., Lotan, D., Nakajima, M., Misiorowski, R.L., Seftor, R.E.B., Stetler-Stevenson, W.G., Bevacqua, S.J., Liotta, L.A., Sobel, M.E., Raz, A., Lotan, R., 1990. Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor. Cancer Res. 50, 4121-4130.
12. Hu, D.N., Stjernschantz, J., McCormick, S.A., 2000. Effect of prostaglandins A (2), E (1), F (2 alpha) and latanoprost on cultured human iridal melanocytes. Exp. Eye Res. 70, 113-120.
13. Ito, S., Wakamatsu, K., Ozeki, H., 2000. Chemical analysis of melanins and its application to the study of the regulation of melanogenesis. Pigment. Cell. Res. 13, 103-109.
14. Kikuchi, A., Shimizu, H., Nishikawa, T., 1996. Expression and ultrastructural localization of HMB-45 antigen. Br. J. Dermatol. 135, 400-405.
15. Li, H., Zhu, W., 2001. Effects of acidum vitamin A on tyrosinase activity. Chin. Med. J. 114, 415-417.
16. Lotan, R., Lotan D., 1980. Stimulation of melanogenesis in a human melanoma cell line by retinoids. Cancer Res. 40, 3345-3350.
17. Lotan, R., Lotan, D., 1981. Enhancement of melanotic expression in cultured mouse melanoma cells by retinoids. J. Cell. Physiol. 106, 179-189.
18. Marks, M.S., Seabra, M.C., 2001. The melanosome: Membrane dynamics in black and white. Nat. Ver. Mol. Cell. Biol. 2, 739-748.
19. Miller, W.H., 1998. The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer. Cancer 15, 1471-1478.
20. Nascimento, A.A.C., Amaral, R.G., Bizario, J.C.S., Larson, R.E., Espreafico, E.M., 1997. Subcellular localization of Myosin-V in the B16 melanoma cells, a wild-type cell line for the dilute gene. Mol. Biol. Cell. 8, 1971-1988.
21. Nedorost, S.T., Bergfeld, W.F., Guitart, J., Fleming, M.G., 1992. Cell cycle analysis by flow cytometry of non-exposed, sun-exposed, and tretinoin-treated skin. J. Cutan. Pathol. 19, 371-375.
22. Niles, R.M., Combs, R., 1996. The relationship between susceptibility to retinoic acid treatment and protein Kinase Cα expression in murine melanoma cell lines. Exp. Cell. Res. 223, 20-28.
23. Niles, R.M., 2002. The use of retinoids in the prevention and treatment of skin cancer. Expert. Opin. Pharmacother. 3, 299-303.
24. Niles, R.M., 2003. Vitamin A (retinoids) regulation of mouse melanoma growth and differentiation. J. Nutr. 133, 282S-286S.
25. Nicolson, G.L., 1978. Experimental tumor metastasis: characteristics and organ specificity. BioScience 28, 441-447.
26. Orlow, S.J., Chakraborty, A.K., Pawelek, J.M., 1990a. Retinoic acid is a potent inhibitor of inducible pigmentation in murine and hamster melanoma cell lines. J. Invest. Dermatol. 94, 461-464.
27. Orlow, S.J., Chakraborty, A.K., Boissy, R.E., Pawelek, J.M., 1990b. Inhibition of induced melanogenesis in Cloudman melanoma cells by four phenotypic modifiers. Exp. Cell. Res. 191, 209-218.
28. Patt, L.M., Itaya, K., Hakomori, S., 1978. Retinol induces density-dependent growth inhibition and changes in glycolipids and LETS. Nature 273, 379-381.
29. Peters, S., Schraemeyer, U., 2001. Characteristics and functions of melanin in retinal pigment epithelium. Ophthalmology 98, 1181-1185.
30. Ramachandra, S.U., Gillet, C.E., Millis, R.R., 1996. A comparative immunohistochemical study of mammary and extramammary Paget's disease and superficial spreading melanoma, with particular emphasis on melanocytic markers. Virch. Arch. 429, 371-376.
31. Robins, E.J., Breathnach, A.S., Bennet, D., Ward, B.J., Bhasin, Y., Ethridge, L., Nazzaro, P.M., Passi, S., Picardo, M., 1985. Ultrastructural observations on the effect of azelaic acid on normal human melanocytes and a human melanoma cell line in tissue culture. Br. J. Dermatol. 113, 687-697.
32. Rosenbaum, S.E., Niles, R.M., 1992. Regulation of protein kinase C gene expression by retinoic acid in B16 mouse melanoma cells. Arch. Biochem. Biophys. 294, 123-129.
33. Slominski, A., Pruski, D., 1993. Melatonin inhibits proliferation and melanogenesis in rodent melanoma cells. Exp. Cell. Res. 206, 189-194.
34. Seiberg, M., Paine, C., Sharlow, E., Andrade-Gordon, P., Costanzo, M., Eisinger, M., Shapiro, S.S., 2000. Inhibition of melanosome transfer results in skin lightening. J. Invest. Dermatol. 115, 162-167.
35. Seiji, M., Shimao, K., Birbeck, M.S.C., Fitzpatrick, T.B., 1961. Subcellular localization of melanin biosynthesis. Ann. N.Y. Acad. Sci. 498-523.
36. Voigt, A., Zintl, F., 2003. Effects of retinoic acid on proliferation, apoptosis, cytoxicity, migration, and invasion of neuroblastoma cells. Med. Pediatr. Oncol. 40, 205-213.
37. Xiao, Y., Desai, D., Quick, T., Niles, R.M., 1996. Control of retinoic acid receptor expression and function in mouse melanoma by cyclic AMP. J. Cell. Physiol. 167, 413-421.
38. Wang, J., Barsky, L.W., Shum, C.H., Jong, A., Weinberg, K.I., Collins, S.J., Triche, T.J., Wu, L., 2002. Retinoid-induced G1 arrest and differentiation activation are associated with a switch to cyclin-dependent kinase-activating kinase hypophosphorylation of retinoic acid receptor alpha. J. Biol. Chem. 277, 43369-43376.
39. Watabe, H., Soma, Y., Ito, M., Kawa, Y., Mizoguchi, M., 2002. All-trans retinoic acid induces differentiation and apoptosis of murine melanocyte precursors with induction of the microphthalmia-associated transcription factor. J. Invest. Dermatol. 118, 35-42.
40. Wischnitzer, S., 1970. The annulate lamellae. Int. Ver. Cytol. 27, 65-100.
41. Zoubolius, C.C., 2001. Retinoids - which dermatological indications will benefit in the near future? Skin. Pharmacol. Appl. Skin. Physiol. 14, 303-315.